Hypertrophic cardiomyopathy

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Coping and support

By Mayo Clinic staff

Being diagnosed with hypertrophic cardiomyopathy can cause a range of difficult emotions and fears. Like many people with this condition, you're likely to struggle with feelings of grief, fear and anger. These are appropriate human responses to the serious changes that come with your diagnosis, including exercise restrictions, a lifelong reliance on medications, fear of death and fear of passing the condition on to your children.

Not surprisingly, people with hypertrophic cardiomyopathy are at increased risk of mental health disorders, including anxiety, depression and substance abuse problems. Talk with your doctor if you are feeling hopeless, panicked or unable to cope. In some cases, you may benefit from medical treatment for these mental health conditions. In other cases, your mental health may benefit most from talking with medical experts, such as your medical care team or a genetic counselor, who can help you understand your risks and find effective ways of coping.

References
  1. Cardiomyopathy. American Heart Association. http://www.americanheart.org/presenter.jhtml?identifier=4468. Accessed Jan. 20, 2009.
  2. Maron BJ. Hypertrophic cardiomyopathy. In: Libby P, et al, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philadelphia, Pa.: Saunders Elsevier; 2007. http://www.mdconsult.com/das/book/body/117866989-4/796148825/1549/451.html#4-u1.0-B978-1-4160-4106-1..50068-6_7427. Accessed Jan. 20, 2009.
  3. Elliot P, et al. Clinical manifestations of hypertrophic cardiomyopathy. http://www.uptodate.com/home/index.html. Accessed Jan. 20, 2009.
  4. Hypertrophic cardiomyopathy. The Merck Manuals Online Medical Library: The Merck Manual for Healthcare Professionals. http://www.merck.com/mmpe/sec07/ch084666/ch084666c.html. Accessed Jan. 20, 2009.
  5. Ferri F. Cardiomyopathy, hypertrophic. In: Ferri FF. Ferri's Clinical Advisor 2009. St. Louis, Mo.: Mosby; 2008:162.
  6. You JJ, et al. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. American Heart Journal. 2007;154:899.
  7. Pigozzi F, et al. Sudden death in competitive athletes. Clinics in Sports Medicine. 2008;27:153.
  8. Maron BJ. Hypertrophic dardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification. Cardiology Clinics. 2007;25:399.
  9. Ingles J. Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy. Genetics in Medicine. 2008;10:117.
  10. Morgan JF, et al. Psychiatric disorders in hypertrophic cardiomyopathy. General Hospital Psychiatry. 2008;30:49.

DS00948

March 25, 2009

© 1998-2009 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Reliable tools for healthier lives," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Text Size: smaller largerlarger